Cancer

News

UroGen's urothelial cancer drug hits target, could prevent s...

Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead d

News

UroGen appoints former Novartis cancer chief Barrett as CEO

Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring its potential urothelial cancer drug to market.

News

AZ appoints controversial doctor to lead new oncology unit

AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle.

News

Sanofi gets opt-in rights to two Regeneron cancer drugs

Sanofi and Regeneron have restructured and extended their immune-oncology discovery and development agreement, giving the French drugmaker rights to opt-in to development and marketing of t

News

Owlstone's ReCIVA is being developed to diagnose lung cancer, but also has applications in precision medicine trials

CRUK and Owlstone launch trial for cancer breath test

Cancer Research UK and Owlstone Medical have launched a clinical trial to develop a breath test that could detect cancer at an early stage – the first test of its kind to investigate multip

News

PureTech's Vedanta raises $27m for microbiome research

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and

UroGen's urothelial cancer drug hits target, could prevent s...

UroGen appoints former Novartis cancer chief Barrett as CEO

AZ appoints controversial doctor to lead new oncology unit

Sanofi gets opt-in rights to two Regeneron cancer drugs

CRUK and Owlstone launch trial for cancer breath test

PureTech's Vedanta raises $27m for microbiome research

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks